Cancer Specific Antigen Equipment
-
by DEARGEN Inc.based in SOUTH KOREA
on targeting and killing cancer cells by delivering drugs that cause cytotoxicity to tumor cells using antibodies that can bind to cancer cell-specific antigens. The Artificial Intelligence algorithm developed by Deargen can derive candidate substances that can control the target protein by predicting the affinity between the ...
-
Manufactured by NexImmune, Inc.based in USA
an AIM™ nanoparticle cocktail that contains multiple tumor-specific antigens and the AIM™ Enrichment and Expansion system. Combined, this propriety approach delivers populations of high quality CD8+ antigen-specific T cells within 14 days — optimized for deep and durable response ...
-
Manufactured by Gritstone Biobased in USA
Gritstone has a program focused on the development of bispecific antibody (BiSAb) therapeutics using highly tumor-specific antigens, including neoantigens, shared between patients with various solid tumors. Our lead BiSAb candidate is currently in IND-enabling studies. The target of this lead program is CT83, a cancer-germline ...
-
Manufactured by Treos Bio Limitedbased in UNITED KINGDOM
Off-the-shelf products contain 6-12 shared tumor-specific antigen derived peptides optimized for a population. They are personalized with a candidate companion diagnostic test (CDx). In silico trials predicted that these peptides induce exceptionally broad T cell responses against at least 3 tumor-specific antigens in high ...
-
Manufactured by Aptevo Therapeuticsbased in USA
APVO603 is a dual agonist bispecific antibody employing a novel mechanism of action to simultaneously target 4-1BB (CD137) and OX40 (CD134), both members of the TNF-receptor family. Dual targeting of 4-1BB and OX40 provides synergistic co-stimulation of T cells with the potential to amplify the cytotoxic function of activated T cells and NK cells, potentially leading to more robust anti-tumor ...
-
Manufactured by Cartherics Pty ltdbased in AUSTRALIA
This technology involves induced pluripotential stem cell (iPSC) derived NK cells (and, potentially, other types of immune cells). iPSCs have unlimited capacity for ...
-
Manufactured by Mol Scientificbased in CHINA
Mol Scientific offer high-quality Tumor-specific antigenic peptide 2 product(MPE0005199). Mol Scientific committed to bring our esteemed customers high quality products and the finest services at highly competitive prices. ...
-
Manufactured by Mol Scientificbased in CHINA
Mol Scientific offer high-quality Tumor-specific antigenic peptide 1 product(MPE0003074). Mol Scientific committed to bring our esteemed customers high quality products and the finest services at highly competitive prices. ...
-
Manufactured by HEALIOS K.K.based in JAPAN
Cancer is the leading cause of death in Japan, with approximately 90% of those deaths said to be caused by solid ...
-
Manufactured by JW Holdingsbased in NORTH KOREA
DC vaccine derived from patient’s own blood cells is the personalized immunotherapeutic vaccine for cancer and auto-immune diseases. Disease specific antigens-loaded dendritic cell allows the immune cells to recognize and attack only cancer cells through a tumor specific antigen recognition ...
-
Manufactured by ORYX GmbH & Co. KGbased in GERMANY
Several cancers arise from the lack of DNA mismatch repair (MMR) resulting in the accumulation of thousands of single deletions or insertions at coding microsatellites (MSI-H). These mutations lead to the inactivation of specific proteins and to the expression of frameshift peptides (FSPs). These FSPs are tumor-specific antigens, ...
-
Manufactured by Bio-Technebased in USA
Immune cell therapy is rapidly emerging as an important alternative for cancer treatment, as well as treatment of autoimmune disease. Also known as adoptive cell therapy or cellular immunotherapy, it supercharges an individual’s immune cells to fight disease. ...
-
based in USA
Metaclipse Therapeutics Corporation is developing novel personalized vaccine immunotherapies for cancer. MembrexTM, a proprietary platform approach tailored to each patient and their specific tumor, consists of ‘membrane vesicles’ prepared from a patient’s tumor tissue that Metaclipse modifies with a ‘protein ...
-
Manufactured by Adicet Biobased in USA
at harnessing the tumor specific immunity of gamma delta T cells. The Company believes that gamma delta T cells have a superior potential compared to alpha beta T cells to be active in both solid tumors and hematological ...
-
Manufactured by Treos Bio Limitedbased in UNITED KINGDOM
At TREOS we use knowledgebase and algorithm embedded in PASCal (Personal Antigen Selection Calculator) tool to develop personal cancer immunotherapies. PASCal supports the development of immunotherapies for single individuals and a population of individuals with a specific genetic background, including specific peptides most ...
-
Manufactured by ViciniVax BVbased in NETHERLANDS
Our first product candidate Vvax001, a therapeutic cancer vaccine against (pre)malignant cervical lesions, is currently in clinical development. We outsource process development and GMP manufacturing to experienced CMO’s, leading to a first clinical trial, which has been started in ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you